1. The constitutive activity of the viral-encoded G protein-coupled receptor US28 supports a complex signalling network contributing to cancer development
   Carole A. Daly et al, 2020, Biochemical Society Transactions CrossRef
2. EP2 Antagonists (2011–2021): A Decade’s Journey from Discovery to Therapeutics
   Madison N. Sluter et al, 2021, Journal of Medicinal Chemistry CrossRef
3. Biological Evaluation, Molecular Docking Analyses, and ADME Profiling of Certain New Quinazolinones as Anti-colorectal Agents
   Nahed N. E. El-Sayed et al, 2022, ACS Omega CrossRef
4. Prodigiosin/celecoxib-loaded into zein/sodium caseinate nanoparticles as a potential therapy for triple negative breast cancer
   Wafaa A. Mohamed et al, 2024, Scientific Reports CrossRef
5. The role of EP-2 receptor expression in cervical intraepithelial neoplasia
   Elisa Schmoeckel et al, 2020, Histochemistry and Cell Biology CrossRef
6. Combination of EP 4 antagonist MF-766 and anti-PD-1 promotes anti-tumor efficacy by modulating both lymphocytes and myeloid cells
   Yun Wang et al, 2021, OncoImmunology CrossRef
7. Hydroethanolic Leaf Extract of Cordia vignei Hutch and Dalziel Inhibits Carrageenan‐Induced Foot Oedema in Chicks, Prostaglandin E2‐Induced Paw Oedema in Mice, and Bradykinin‐Induced Paw Oedema in Mice
   George Owusu et al, 2023, Evidence-Based Complementary and Alternative Medicine CrossRef
8. Phosphatidylcholine-Derived Lipid Mediators: The Crosstalk Between Cancer Cells and Immune Cells
   Renata de Freitas Saito et al, 2022, Frontiers in Immunology CrossRef
9. Natural Inhibitors against Potential Targets of Cyclooxygenase, Lipoxygenase and Leukotrienes
   Anil Kumar Saxena et al, 2022, Combinatorial Chemistry & High Throughput Screening CrossRef